THE HAZARDS OF USING TYPE-1C ANTIARRHYTHMIC DRUGS FOR THE TREATMENT OF PAROXYSMAL ATRIAL-FIBRILLATION

被引：64

作者：

MARCUS, FI ^{[1
]}

机构：

[1] UNIV ARIZONA, ARIZONA HLTH SCI CTR, DEPT INTERNAL MED, CARDIOL SECT, TUCSON, AZ 85724 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1990年 / 66卷 / 03期

关键词：

D O I：

10.1016/0002-9149(90)90851-Q

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：366 / 367

页数：2

共 8 条

[1] FLECAINIDE-INDUCED VENTRICULAR-TACHYCARDIA AND FIBRILLATION IN PATIENTS TREATED FOR ATRIAL-FIBRILLATION [J].

FALK, RH .

ANNALS OF INTERNAL MEDICINE, 1989, 111 (02) :107-111

[2] POSSIBLE ATRIAL PROARRHYTHMIC EFFECTS OF CLASS-1C ANTIARRHYTHMIC DRUGS [J].

FELD, GK ;

CHEN, PS ;

NICOD, P ;

FLECK, RP ;

MEYER, D .

AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (03) :378-383

[3] PROPAFENONE FOR PREVENTION OF RECURRENT ATRIAL-FIBRILLATION [J].

KERR, CR ;

KLEIN, GJ ;

AXELSON, JE ;

COOPER, JC .

AMERICAN JOURNAL OF CARDIOLOGY, 1988, 61 (11) :914-916

[4]

MARCUS F I, 1990, Journal of the American College of Cardiology, V15, p201A

[5]

MENDEZ R, 1953, J PHARMACOL EXP THER, V107, P24

[6] ATRIAL-FLUTTER IN PATIENTS TREATED FOR ATRIAL-FIBRILLATION WITH PROPAFENONE [J].

MURDOCK, CJ ;

KYLES, AE ;

YEUNGLAIWAH, JA ;

QI, AH ;

VORDERBRUGGE, S ;

KERR, CR .

AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (07) :755-757

[7]

NACCARELLI GV, 1989, CIRCULATION S2, V80, pA634

[8]

WEINER H L, 1990, Journal of the American College of Cardiology, V15, p193A

← 1 →